|
|
Article: TOSITUMOMAB.(review status)(Brief Article)
- Article from:
- Chemical Market Reporter
- Article date:
- August 30, 1999
CopyrightCOPYRIGHT 1999 Schnell Publishing Company, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Coulter Pharmaceutical Inc. and SmithKline Beecham have received priority review status from FDA for Bexxar (tositumomab, iodine I 131 ...
Related newspaper, magazine, and journal articles:
|
|
Article: SmithKline Beecham,Related Entities Rtgs Raised by ...
Business Wire;
June 11, 1997 ;
700+ words
... ... s today has raised its ratings on SmithKline Beecham PLC and related entities (see list ... improvements over the past three years in SmithKline Beecham's business profile, in conjunction ... s leading health care company, SmithKline Beecham has made no major acquisitions in ...
|
|